AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
+14.56%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$4.91B
AUM Growth
+$4.91B
(+98%)
Cap. Flow
+$2.58B
Cap. Flow
% of AUM
52.53%
Top 10 Holdings %
Top 10 Hldgs %
89.16%
Holding
40
New
8
Increased
1
Reduced
7
Closed
4
Top Buys
| 1 |
UiPath
PATH
|
$1.97B |
| 2 |
VERV
Verve Therapeutics
VERV
|
$661M |
| 3 |
Lyell Immunopharma
LYEL
|
$95.3M |
| 4 |
Monte Rosa Therapeutics
GLUE
|
$33.2M |
| 5 |
BRNS
Barinthus Biotherapeutics
BRNS
|
$28.6M |
Top Sells
| 1 |
Upstart Holdings
UPST
|
$107M |
| 2 |
DM
Desktop Metal, Inc.
DM
|
$37.4M |
| 3 |
Opendoor
OPEN
|
$26.5M |
| 4 |
Airbnb
ABNB
|
$25.4M |
| 5 |
Lyft
LYFT
|
$17.1M |
Sector Composition
| 1 | Technology | 48.99% |
| 2 | Healthcare | 46.65% |
| 3 | Industrials | 2.59% |
| 4 | Consumer Discretionary | 1.64% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$5.95B
| $1.97B | 40.17% | +29,025,785 | New | +$1.97B |
|
|
VERV
2
DELISTED
Verve Therapeutics
VERV
| $661M | 13.47% | +10,974,011 | New | +$661M |
|
3
Oscar Health
OSCR
$4.31B
| $517M | 10.53% | 24,042,864 | – | – |
|
|
4
Lyft
LYFT
$6.73B
| $371M | 7.56% | 6,138,154 -282,831 | -4% | -$17.1M |
|
5
DexCom
DXCM
$29.5B
| $344M | 7.01% | 805,681 | – | – |
|
|
DM
6
DELISTED
Desktop Metal, Inc.
DM
| $127M | 2.59% | 11,048,730 -3,253,708 | -23% | -$37.4M |
|
7
Arcus Biosciences
RCUS
$1.13B
| $127M | 2.58% | 4,613,818 -109,530 | -2% | -$3.01M |
|
|
8
Lyell Immunopharma
LYEL
$213M
| $95.3M | 1.94% | +5,865,125 | New | +$95.3M |
|
9
Beam Therapeutics
BEAM
$1.66B
| $81.8M | 1.67% | 635,586 -5,206 | -0.8% | -$670K |
|
|
10
Airbnb
ABNB
$79.9B
| $80.5M | 1.64% | 525,626 -165,986 | -24% | -$25.4M |
|
11
Relay Therapeutics
RLAY
$619M
| $66.8M | 1.36% | 1,826,876 +258,390 | +16% | +$9.45M |
|
|
WORK
12
DELISTED
Slack Technologies, Inc.
WORK
| $57.6M | 1.17% | 1,299,771 | – | – |
|
13
Sana Biotechnology
SANA
$777M
| $55.3M | 1.13% | 2,812,500 | – | – |
|
14
Clover Health Investments
CLOV
$1.34B
| $54.8M | 1.12% | 4,113,742 | – | – |
|
|
KRON
15
DELISTED
Kronos Bio
KRON
| $34.4M | 0.7% | 1,438,232 | – | – |
|
|
16
Monte Rosa Therapeutics
GLUE
$296M
| $33.2M | 0.68% | +1,464,015 | New | +$33.2M |
|
17
Dianthus Therapeutics
DNTH
$759M
| $32.7M | 0.67% | 3,339,138 | – | – |
|
|
BRNS
18
Barinthus Biotherapeutics
BRNS
$45.6M
| $28.6M | 0.58% | +1,704,444 | New | +$28.6M |
|
19
RAPT Therapeutics
RAPT
$188M
| $25.1M | 0.51% | 788,813 -42,441 | -5% | -$1.35M |
|
|
OMIC
20
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $17.8M | 0.36% | +646,622 | New | +$17.8M |
|
21
IDEAYA Biosciences
IDYA
$2.15B
| $15.8M | 0.32% | 753,187 | – | – |
|
|
EVLO
22
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $14.6M | 0.3% | 1,060,495 | – | – |
|
|
DBTX
23
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $14.1M | 0.29% | 1,636,258 | – | – |
|
24
Taysha Gene Therapies
TSHA
$797M
| $13.6M | 0.28% | 640,882 | – | – |
|
25
Vera Therapeutics
VERA
$1.38B
| $12.5M | 0.26% | +944,791 | New | +$12.5M |
|